Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 49,503 | 38,190 | 21,884 | 11,628 | 2,645 |
| Cost of Goods | 21,497 | 16,606 | 12,607 | 7,584 | 2,925 |
| Gross Profit | 28,006 | 21,584 | 9,277 | 4,044 | -280 |
| Operating Expenses | 61,969 | 51,196 | 33,057 | 23,557 | 15,911 |
| Operating Income | -33,466 | -29,006 | -23,173 | -18,929 | -15,266 |
| Interest Expense | 378 | 439 | 233 | 0 | 0 |
| Other Income | 140 | 72 | -2,174 | 280 | 821 |
| Pre-tax Income | -33,704 | -29,373 | -25,580 | -18,649 | -14,445 |
| Net Income Continuous | -33,704 | -29,373 | -25,580 | -18,649 | -14,445 |
| Net Income | $-33,704 | $-29,373 | $-25,580 | $-18,649 | $-14,445 |
| EPS Basic Total Ops | -1.30 | -1.36 | -6.15 | -28.68 | -24.90 |
| EPS Basic Continuous Ops | -1.30 | -1.36 | -6.15 | -28.69 | -24.91 |
| EPS Diluted Total Ops | -1.30 | -1.36 | -6.15 | -28.68 | -24.90 |
| EPS Diluted Continuous Ops | -1.30 | -1.36 | -6.15 | -28.69 | -24.91 |
| EBITDA(a) | $-33,063 | $-30,003 | $-24,618 | $-20,609 | $-14,655 |